Clinical trial
Homocysteine Study (HOST)
NCT00032435 · US Department of Veterans Affairs, U.S. Fed · Completed
Key facts
| NCT number | NCT00032435 |
|---|---|
| Title | Homocysteine Study (HOST) |
| Official title | CSP #453 - Homocysteinemia in Kidney and Endstage Renal Disease Study (HOST) |
| Lead sponsor | US Department of Veterans Affairs, U.S. Fed |
| Collaborators | Pan American Laboratories Industry Abbott Diagnostics Division |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | End Stage Renal Disease, Renal Failure |
| Intervention type | Drug |
| Interventions | PAL-40 Active, PAL-40 Placebo |
| Enrollment | 2,003 |
| Start date | May 1, 2001 |
| Primary completion | Aug 1, 2006 |
| Completion | Sep 1, 2006 |
| First posted | Mar 22, 2002 |
| Last update posted | Oct 15, 2010 |
| Countries | Puerto Rico, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: